Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors

Clinical trial NCT06814496 · RECRUITING

Trial details

NCT number: NCT06814496
Sponsor: University of Arizona
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Melanoma Medullary Thyroid Cancer Sinonasal Undifferentiated Carcinoma Esthesioneuroblastoma Bladder Cancer Testicular Cancer Glioblastoma Multiforme Cervical Cancer Large Cell Neuroendocrine Carcinoma of the Lung Non Small Cell Lung Cancer Merkel Cell Carcinoma

Start date: 2025-09-08
Primary completion: 2030-05-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.